Literature DB >> 26336516

The optimal setting of complex fractionated atrial electrogram software in substrate ablation for atrial fibrillation.

Fuminori Namino1, Yasuhisa Iriki2, Ryuichi Maenosono3, Hitoshi Ichiki2, Hideki Okui2, Akino Yoshimura2, Naoya Oketani2, Masakaze Matsushita3, Mitsuru Ohishi2, Teruto Hashiguchi1.   

Abstract

BACKGROUND: Complex fractionated atrial electrogram (CFAE)-targeted catheter ablation (CFAE ablation) requires a high rate of atrial fibrillation (AF) termination to provide good outcomes. We determined the optimal settings of CFAE software.
METHODS: In our 430 consecutive patients, AF was terminated in 97 (234/242) and 79% (149/188) of patients with paroxysmal and persistent AF, respectively, by CFAE ablation combined with (31%) or without (69%) pulmonary vein isolation, occasionally with nifekalant infusion. We analyzed 109 consecutive patients who underwent CFAE ablation to determine the optimal settings for comparing subjective versus objective decisions by the CFAE software on CARTO3. We compared three settings: the default setting (0.05-0.15 mV, 50-120 ms) and two modified settings (#1: 0.05-0.30 mV, 40-70 ms, #2: 0.05-0.13 mV, 10-20 ms). We retrospectively analyzed 11,425 points during left atrial mapping before ablation and 10,306 points that were subjectively detected and ablated as CFAE points. An interval confidence level ≥6 denoted a site with CFAE.
RESULTS: With the default setting, the accuracy, sensitivity, specificity, positive productive value, and negative productive values were 67, 42, 77, 48, and 73%, respectively. With modified setting #1, the values were 78, 55, 87, 74, and 77%, respectively, versus 64, 82, 60, 53, and 91%, respectively, for modified setting #2.
CONCLUSION: These data suggest that setting #1 was generally superior to the default setting, whereas setting #2 was optimal for excluding areas not requiring ablation. The optimal CFAE software setting was a voltage of 0.05-0.30 mV and an interval parameter of 40-70 ms.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Complex fractionated atrial electrograms; Optimal setting

Year:  2014        PMID: 26336516      PMCID: PMC4550232          DOI: 10.1016/j.joa.2014.04.006

Source DB:  PubMed          Journal:  J Arrhythm        ISSN: 1880-4276


  24 in total

Review 1.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

2.  Efficacy of linear block at the left atrial roof in atrial fibrillation.

Authors:  Michiharu Senga; Eitaro Fujii; Shinya Sugiura; Shoichiro Yamazato; Emiyo Sugiura; Mashio Nakamura; Masatoshi Miyahara; Masaaki Ito
Journal:  J Cardiol       Date:  2010-01-25       Impact factor: 3.159

3.  Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

4.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

5.  Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison.

Authors:  Stephan Willems; Hanno Klemm; Thomas Rostock; Benedikt Brandstrup; Rodolfo Ventura; Daniel Steven; Tim Risius; Boris Lutomsky; Thomas Meinertz
Journal:  Eur Heart J       Date:  2006-06-16       Impact factor: 29.983

6.  A tailored approach to catheter ablation of paroxysmal atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Eric Good; Sundar Sankaran; Stephen S Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Thomas Crawford; Sujoya Dey; Alan Wimmer; Kristina Lemola; Krit Jongnarangsin; Frank Bogun; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2006-04-10       Impact factor: 29.690

7.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

8.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

9.  Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation.

Authors:  Heidi Luise Estner; Gabriele Hessling; Gjin Ndrepepa; Jinjin Wu; Tilko Reents; Stefanie Fichtner; Claus Schmitt; Christian V Bary; Christof Kolb; Martin Karch; Bernhard Zrenner; Isabel Deisenhofer
Journal:  Europace       Date:  2008-08-29       Impact factor: 5.214

10.  Is pulmonary vein isolation necessary for curing atrial fibrillation?

Authors:  Giuseppe Stabile; Pietro Turco; Vincenzo La Rocca; Pasquale Nocerino; Eugenio Stabile; Antonio De Simone
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

View more
  1 in total

Review 1.  Atrial Fibrillation Mechanisms and Implications for Catheter Ablation.

Authors:  Ghassen Cheniti; Konstantinos Vlachos; Thomas Pambrun; Darren Hooks; Antonio Frontera; Masateru Takigawa; Felix Bourier; Takeshi Kitamura; Anna Lam; Claire Martin; Carole Dumas-Pommier; Stephane Puyo; Xavier Pillois; Josselin Duchateau; Nicolas Klotz; Arnaud Denis; Nicolas Derval; Pierre Jais; Hubert Cochet; Meleze Hocini; Michel Haissaguerre; Frederic Sacher
Journal:  Front Physiol       Date:  2018-10-17       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.